Role of angiogenesis inhibitors in acute myeloid leukemia.

Cancer journal (Sudbury, Mass.)

Volumn 7 Suppl 3, Issue , 2001, Pages

  Fiedler, W ^a   Staib, P ^a   Kuse, R ^a   Duhrsen U ^a   Flasshove, M ^a   Cavalli, F ^a   Hossfeld, D K ^a   Berdel, W E ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; ENDOTHELIAL CELL GROWTH FACTOR; INDOLE DERIVATIVE; LYMPHOKINE; PYRROLE DERIVATIVE; SEMAXANIB; VASCULOTROPIN; VASCULOTROPIN A;

ACUTE DISEASE; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; MULTICENTER STUDY; MYELOID LEUKEMIA; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHASE 2 CLINICAL TRIAL; REVIEW; VASCULAR ENDOTHELIUM;

ACUTE DISEASE; ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; CLINICAL TRIALS, PHASE II; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; HUMANS; INDOLES; LEUKEMIA, MYELOID; LYMPHOKINES; MULTICENTER STUDIES; NEOVASCULARIZATION, PATHOLOGIC; PYRROLES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0000032831     PISSN: 15289117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)